| 发明名称 |
Sustained release dosage forms of ziprasidone |
| 摘要 |
A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
|
| 申请公布号 |
US2007190129(A1) |
申请公布日期 |
2007.08.16 |
| 申请号 |
US20040931143 |
申请日期 |
2004.08.31 |
| 申请人 |
PFIZER INC. |
发明人 |
AHMED IMRAN;APPEL LEAH E.;BABCOCK WALTER C.;FRIESEN DWAYNE T.;HERBIG SCOTT;LYON DAVID K.;SHAMBLIN SHERI L.;SHANKER RAVI M.;SMITHEY DANIEL T.;SUTTON STEVEN C.;THOMBRE AVINASH G.;WATERMAN KENNETH C. |
| 分类号 |
A61K9/48;A61K9/00;A61K9/16;A61K9/20;A61K9/52;A61K31/496;A61K31/4965 |
主分类号 |
A61K9/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
